Expression of METTL7A in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

METTL7A is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 104.95

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

87.0

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	425.4
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	335.4
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	242.0
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	232.4
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	214.8
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	201.7
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	199.7
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	195.3
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	194.8
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	194.5
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	185.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	176.0
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	175.4
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	170.1
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	168.4
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	165.9
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	163.7
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	159.2
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	158.4
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	155.6
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	153.0
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	148.8
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	132.3
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	132.1
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	129.7
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	129.4
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	119.9
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	118.8
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	116.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	116.1
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	110.6
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	107.8
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	105.6
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	104.3
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	103.7
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	102.1
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	101.8
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	100.7
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	100.1
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	99.3
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	99.0
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	98.8
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	97.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	96.2
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	94.9
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	94.6
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	92.8
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	92.4
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	92.0
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	90.6
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	90.2
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	88.4
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	88.3
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	88.2
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	88.2
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	83.1
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	81.9
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	81.4
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	80.3
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	80.2
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	79.9
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	77.0
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	76.4
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	75.8
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	74.0
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	72.4
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	72.0
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	71.5
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	71.4
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	70.1
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	69.7
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	69.2
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	69.2
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	68.5
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	65.8
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	65.5
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	64.8
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	63.7
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	63.4
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	62.6
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	62.1
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	62.0
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	61.1
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	59.8
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	59.7
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	59.7
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	58.7
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	58.4
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	57.9
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	56.3
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	56.1
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	55.9
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	54.8
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	54.7
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	54.7
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	54.5
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	54.2
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	52.9
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	52.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	52.5
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	52.5
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	52.0
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	51.6
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	50.8
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	49.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	49.7
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	48.7
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	48.1
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	47.8
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	47.0
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	45.8
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	45.3
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	43.5
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	42.5
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	42.5
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	40.8
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	40.2
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	40.1
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	39.8
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	38.7
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	38.7
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	38.6
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	37.2
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	35.5
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	34.3
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	32.8
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	32.3
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	32.2
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	31.8
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	31.2
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	26.6
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	26.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	23.9
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	23.7
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	22.5
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	21.5
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	18.6
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	18.4
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	18.2
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	16.5
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	13.8
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

METTL7A is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 34.3

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

48.7

Number of samples

Samples

Sample	Description	TPM
AK139	N, NA, stage:NA, dead, 270 days	155.8
AK006	N, NA, stage:NA, dead, 360 days	151.5
AK088	N, NA, stage:NA, dead, 360 days	133.7
AK041	N, NA, stage:NA, alive, 810 days	94.0
AK055	N, NA, stage:NA, dead, 240 days	88.0
AK030	N, NA, stage:NA, dead, 120 days	84.5
AK098	N, NA, stage:NA, dead, 660 days	82.7
AK178	N, NA, stage:NA, dead, 240 days	81.8
AK226	N, NA, stage:NA, dead, 360 days	77.1
AK153	N, NA, stage:NA, dead, 240 days	76.8
AK188	N, NA, stage:NA, alive, 420 days	76.2
AK195	N, NA, stage:NA, dead, 390 days	75.6
AK091	N, NA, stage:NA, dead, 210 days	72.6
AK071	N, NA, stage:NA, dead, 540 days	69.7
AK227	N, NA, stage:NA, alive, 300 days	65.6
AK158	N, NA, stage:NA, dead, 360 days	60.9
AK231	N, NA, stage:NA, dead, 240 days	60.8
AK015	N, NA, stage:NA, alive, 720 days	59.8
AK099	N, NA, stage:NA, dead, 420 days	56.7
AK081	N, NA, stage:NA, dead, 180 days	56.0
AK005	N, NA, stage:NA, dead, 240 days	52.4
AK100	N, NA, stage:NA, alive, 960 days	50.3
AK167	N, NA, stage:NA, dead, 180 days	50.3
AK089	N, NA, stage:NA, dead, 330 days	48.2
AK165	N, NA, stage:NA, alive, 360 days	47.5
AK185	N, NA, stage:NA, alive, 330 days	45.0
AK183	N, NA, stage:NA, alive, 360 days	44.9
AK133	N, NA, stage:NA, dead, 360 days	43.8
AK035	N, NA, stage:NA, dead, 210 days	43.6
AK216	N, NA, stage:NA, dead, 360 days	42.6
AK117	N, NA, stage:NA, dead, 210 days	40.7
AK236	N, NA, stage:NA, dead, 360 days	39.8
AK134	N, NA, stage:NA, dead, 360 days	35.8
AK074	N, NA, stage:NA, alive, 300 days	32.8
AK213	N, NA, stage:NA, alive, 2010 days	32.2
AK049	N, NA, stage:NA, dead, 180 days	31.7
AK124	N, NA, stage:NA, alive, 1920 days	30.3
AK053	N, NA, stage:NA, dead, 300 days	28.4
AK218	N, NA, stage:NA, dead, 180 days	27.5
AK066	N, NA, stage:NA, alive, 960 days	26.8
AK085	N, NA, stage:NA, alive, 660 days	26.7
AK123	N, NA, stage:NA, dead, 180 days	26.4
AK072	N, NA, stage:NA, dead, 150 days	23.9
AK079	N, NA, stage:NA, dead, 210 days	23.7
AK068	N, NA, stage:NA, alive, 360 days	23.6
AK102	N, NA, stage:NA, alive, 1740 days	22.7
AK051	N, NA, stage:NA, dead, 360 days	22.2
AK149	N, NA, stage:NA, dead, 420 days	21.5
AK076	N, NA, stage:NA, alive, 660 days	20.1
AK156	N, NA, stage:NA, dead, 330 days	19.9
AK173	N, NA, stage:NA, dead, 180 days	19.8
AK205	N, NA, stage:NA, dead, 120 days	19.4
AK103	N, NA, stage:NA, alive, 1320 days	19.1
AK003	N, NA, stage:NA, dead, 600 days	17.6
AK142	N, NA, stage:NA, alive, 90 days	15.6
AK199	N, NA, stage:NA, alive, 1860 days	14.4
AK002	N, NA, stage:NA, dead, 570 days	10.2
AK043	N, NA, stage:NA, alive, 660 days	7.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0221180003	Tumor	1.6
CPT0093590003	Tumor	1.4
CPT0182500003	Tumor	1.2
CPT0201710003	Tumor	1.2
CPT0190240004	Tumor	1.0
CPT0127480003	Tumor	1.0
CPT0219080004	Tumor	0.9
CPT0093450003	Tumor	0.8
CPT0205780003	Tumor	0.7
CPT0189750004	Tumor	0.7
CPT0216920008	Tumor	0.6
CPT0189460003	Tumor	0.6
CPT0186100003	Tumor	0.6
CPT0087950003	Tumor	0.6
CPT0199770003	Tumor	0.6
CPT0162140003	Tumor	0.6
CPT0168080003	Tumor	0.6
CPT0125570003	Tumor	0.6
CPT0218890004	Tumor	0.5
CPT0167640003	Tumor	0.5
CPT0218670003	Tumor	0.5
CPT0125220003	Tumor	0.5
CPT0168270003	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0206780003	Tumor	0.4
CPT0189650004	Tumor	0.4
CPT0217190003	Tumor	0.3
CPT0206880003	Tumor	0.3
CPT0218830004	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0224330003	Tumor	0.3
CPT0093550003	Tumor	0.3
CPT0093360003	Tumor	0.3
CPT0218960004	Tumor	0.3
CPT0104220003	Tumor	0.2
CPT0171580008	Tumor	0.2
CPT0217710008	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0218330004	Tumor	0.2
CPT0189250003	Tumor	0.2
CPT0092440003	Tumor	0.1
CPT0208980003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0078580003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0206230003	Tumor	0.1
CPT0205890003	Tumor	0.1
CPT0218690004	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0217060003	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0204360003	Normal	0.0
CPT0206330003	Tumor	0.0
CPT0079790003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0206000004	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0167530003	Tumor	-0.1
CPT0168480003	Tumor	-0.1
CPT0196850003	Tumor	-0.1
CPT0206670004	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0225730003	Tumor	-0.2
CPT0167750004	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0125510003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0089150003	Tumor	-0.2
CPT0204370003	Normal	-0.3
CPT0204380003	Normal	-0.3
CPT0217000004	Tumor	-0.3
CPT0167970003	Tumor	-0.3
CPT0205450004	Tumor	-0.3
CPT0224390004	Tumor	-0.3
CPT0168380003	Tumor	-0.3
CPT0104330003	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0204330003	Normal	-0.4
CPT0189850004	Tumor	-0.4
CPT0204400003	Normal	-0.4
CPT0182580003	Tumor	-0.4
CPT0204420003	Normal	-0.4
CPT0206450003	Tumor	-0.5
CPT0225760003	Tumor	-0.5
CPT0087730003	Tumor	-0.5
CPT0204340003	Normal	-0.5
CPT0064650003	Tumor	-0.5
CPT0204410003	Normal	-0.5
CPT0204390003	Normal	-0.5
CPT0207030003	Tumor	-0.6
CPT0162020003	Tumor	-0.6
CPT0123530003	Tumor	-0.6
CPT0224540004	Tumor	-0.6
CPT0093510003	Tumor	-0.7
CPT0071100003	Tumor	-0.7
CPT0167860004	Tumor	-0.7
CPT0204350003	Normal	-0.8
CPT0217430008	Tumor	-0.8
CPT0206560003	Tumor	-0.9
CPT0205670004	Tumor	-1.0
CPT0228220003	Tumor	-1.3
CPT0207090003	Tumor	-1.3
CPT0218770003	Tumor	-1.6
CPT0161730003	Tumor	-1.8
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis